comparemela.com

Latest Breaking News On - Brian varnum - Page 3 : comparemela.com

Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company s Bacteriophage Development

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allaireSteve martinLifesci advisorsArmata pharmaceuticals incThompson hineWillkie farr gallagherLadenburg thalmann coInnoviva incInnoviva strategic opportunitiesArmata pharmaceuticalsChief executive officerLadenburg thalmannSecurities actAnnual report

Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company s Bacteriophage Development

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesBrian varnumJoyce allaireSteve martinLifesci advisorsArmata pharmaceuticals incThompson hineWillkie farr gallagherLadenburg thalmann coInnoviva incInnoviva strategic opportunitiesArmata pharmaceuticalsChief executive officerLadenburg thalmannSecurities actAnnual report

Armata Enters Lease To Build State-Of-The-Art R&D And GMP Manufacturing Facility

Armata Pharmaceuticals, Inc.("Armata," "us," "our," or the "Company"), a biotechnology company focused on.

United statesBrian varnumLos angelesArmata pharmaceuticals incDel reyChief executive officerArmata pharmaceuticals

Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata," "us," "our," or the "Company"), a biotechnology company focused on.

United statesBrian varnumMina pastagiaJoyce allaireSteve martinLifesci advisorsArmata pharmaceuticals incTherapeutics development awardCf foundationCystic fibrosis foundation cfInnoviva incInnoviva strategic opportunitiesClinical development at armataArmata pharmaceuticalsCystic fibrosis foundationVice president

Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata," "us," "our," or the "Company"), a biotechnology company focused on.

United statesBrian varnumMina pastagiaJoyce allaireSteve martinLifesci advisorsArmata pharmaceuticals incTherapeutics development awardCf foundationCystic fibrosis foundation cfInnoviva incInnoviva strategic opportunitiesClinical development at armataArmata pharmaceuticalsCystic fibrosis foundationVice president

vimarsana © 2020. All Rights Reserved.